Clinical Trial Update: A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 study assessing the safety and efficacy of intravenous Elezanumab in adults with acute ischemic stroke has completed, with results posted on 2025-12-2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Elezanumab (elezanumab)

Snippet

Sponsor: AbbVie | Conditions: Acute Ischemic Stroke | Phase 2 | Status: COMPLETED | Results posted: 2025-12-22